EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints — George Βertsias (2008) | RDL Network
Caroline Gordon, George Βertsias, John P A Ioannidis, J. Boletis, Stefano Bombardieri, Ricard Cervera, C Dostál, Josep Font, I-M Gilboe, Frédéric Houssiau, T. Huizinga, David Isenberg, C. G. M. Kallenberg, Munther A. Khamashta, J.C. Pietté, M. Schneider, Josef S Smolen, Gunnar Sturfelt, Anǵela Tincani, Ronald van Vollenhoven, Dimitrios T. Boumpas
George Βertsias, John P A Ioannidis, J. Boletis, Stefano Bombardieri, Ricard Cervera, C Dostál, Josep Font, I-M Gilboe, F. Houssiau, T. Huizinga, David Isenberg, C. G. M. Kallenberg, M A Khamashta, J.C. Pietté, M. Schneider, Josef S Smolen, Gunnar Sturfelt, Anǵela Tincani, Ronald van Vollenhoven, Caroline Gordon, Dimitrios T. Boumpas
George Βertsias, John P A Ioannidis, Martin Aringer, E. Bollen, Stefano Bombardieri, Ian N Bruce, Ricard Cervera, Marinos C. Dalakas, Andrea Doria, John G. Hanly, T. Huizinga, David Isenberg, C. G. M. Kallenberg, J.C. Pietté, M. Schneider, Neil Scolding, Josef S Smolen, A Stara, Ioannis Tassiulas, Maria G. Tektonidou, Anǵela Tincani,
Discussion(0)
No comments yet. Be the first to comment.